` Comparison: IXC vs LLY - Alpha Spread

IXC
vs
LLY

Over the past 12 months, IXC has significantly outperformed LLY, delivering a return of +100% compared to the LLY's +19% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
IXC
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

IXC Intrinsic Value
HIDDEN
Show
LLY Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Invex Therapeutics Ltd
ASX:IXC
0.12 AUD
Eli Lilly and Co
NYSE:LLY
990.33 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
IXC, LLY

IXC
LLY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Invex Therapeutics Ltd
Revenue
Eli Lilly and Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
IXC, LLY

IXC
LLY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Invex Therapeutics Ltd
ASX:IXC
Eli Lilly and Co
NYSE:LLY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

IXC
0%
LLY
83%

Operating Margin

IXC
-176.6%
LLY
45.6%

Net Margin

IXC
-176.6%
LLY
31.7%

FCF Margin

IXC
-251%
LLY
9.2%

ROE

IXC
-16.8%
LLY
101.4%

ROA

IXC
-15.8%
LLY
21.6%

ROIC

IXC
355.2%
LLY
27.7%

ROCE

IXC
-16.8%
LLY
46.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
IXC, LLY

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IXC, LLY

Performance Gap Between IXC and LLY
HIDDEN
Show

Performance By Year
IXC, LLY

Loading
IXC
LLY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare IXC to other stocks
JNJ
Johnson & Johnson
Cheaper
vs IXC
ROG
Roche Holding AG
Cheaper
vs IXC
NOVN
Novartis AG
Cheaper
vs IXC
AZN
AstraZeneca PLC
Cheaper
vs IXC
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett